These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25699021)

  • 21. Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor.
    Li J; Wu J; Hall C; Bai XC; Choi E
    Elife; 2022 Nov; 11():. PubMed ID: 36413010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
    Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-atom structural models for complexes of insulin-like growth factors IGF1 and IGF2 with their cognate receptor.
    Vashisth H; Abrams CF
    J Mol Biol; 2010 Jul; 400(3):645-58. PubMed ID: 20488191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like modulation of Akt/FoxO signaling by copper ions is independent of insulin receptor.
    Hamann I; Petroll K; Grimm L; Hartwig A; Klotz LO
    Arch Biochem Biophys; 2014 Sep; 558():42-50. PubMed ID: 24933099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
    Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
    Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF1R signalling and its inhibition.
    Riedemann J; Macaulay VM
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S33-43. PubMed ID: 17259557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hypoxia on the expression of genes encoding insulin-like growth factors and some related proteins in U87 glioma cells without IRE1 function.
    Minchenko DO; Kharkova AP; Halkin OV; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2016 Apr; 50(2):43-54. PubMed ID: 27560636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
    Blanquart C; Boute N; Lacasa D; Issad T
    Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coevolution of insulin-like growth factors, insulin and their receptors and binding proteins in New World Monkeys.
    Wallis M
    Growth Horm IGF Res; 2015 Aug; 25(4):158-67. PubMed ID: 26072449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF1R and c-met as therapeutic targets for colorectal cancer.
    Shali H; Ahmadi M; Kafil HS; Dorosti A; Yousefi M
    Biomed Pharmacother; 2016 Aug; 82():528-36. PubMed ID: 27470393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy.
    Werner H; Sarfstein R; Bruchim I
    Expert Opin Investig Drugs; 2019 Dec; 28(12):1101-1112. PubMed ID: 31731883
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin-like growth factor 1/insulin-like growth factor 1 receptor signaling protects against cell apoptosis through the PI3K/AKT pathway in glioblastoma cells.
    Zhang M; Liu J; Li M; Zhang S; Lu Y; Liang Y; Zhao K; Li Y
    Exp Ther Med; 2018 Aug; 16(2):1477-1482. PubMed ID: 30116397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor (IGF) 2 stimulates steroidogenesis and mitosis of bovine granulosa cells through the IGF1 receptor: role of follicle-stimulating hormone and IGF2 receptor.
    Spicer LJ; Aad PY
    Biol Reprod; 2007 Jul; 77(1):18-27. PubMed ID: 17360960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.
    Browne BC; Eustace AJ; Kennedy S; O'Brien NA; Pedersen K; McDermott MS; Larkin A; Ballot J; Mahgoub T; Sclafani F; Madden S; Kennedy J; Duffy MJ; Crown J; O'Donovan N
    Breast Cancer Res Treat; 2012 Dec; 136(3):717-27. PubMed ID: 23117852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice.
    Pitetti JL; Torre D; Conne B; Papaioannou MD; Cederroth CR; Xuan S; Kahn R; Parada LF; Vassalli JD; Efstratiadis A; Nef S
    Sex Dev; 2009; 3(5):264-72. PubMed ID: 19851056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas.
    Potratz JC; Saunders DN; Wai DH; Ng TL; McKinney SE; Carboni JM; Gottardis MM; Triche TJ; Jürgens H; Pollak MN; Aparicio SA; Sorensen PH
    Cancer Res; 2010 Nov; 70(21):8770-81. PubMed ID: 20959493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R.
    Raile K; Klammt J; Schneider A; Keller A; Laue S; Smith R; Pfäffle R; Kratzsch J; Keller E; Kiess W
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2264-71. PubMed ID: 16569742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.